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This project is a branch off of another project that involves finding transcriptional changes 
expressed in variant colonies within Pseudomonas aeruginosa biofilms. Preliminary in vitro 
studies have shown that in the presence of a tobramycin bead, many different phenotypic colonies, 
dubbed variants, appeared within the biofilm. P. aeruginosa is normally susceptible towards 
tobramycin, but these variant colonies are able to survive the effects of the antibiotic whether 
through tolerance, resistance, or by some other mechanism. In a separate study testing antibiotic 
bead combinations with Staphylococcus aureus, a similar phenomenon was occurring with 
gentamicin. Although it is uncertain that these variant colonies are similar to P. aeruginosa, for 
this project both types of colonies fall under the umbrella term variant. Being able to understand 
these variant colonies of bacteria can greatly improve the approach when treating bacterial 
infections, especially when it comes to recurring infections.  
 
This study investigates antibiotic efficacy against planktonic vs biofilm bacteria in vitro, using 
eight different antibiotics: carbenicillin, ciprofloxacin, colistin, gentamicin, meropenem, 
rifampicin, tobramycin, and vancomycin. The main aim is to see which antibiotic can best clear 
the biofilm, which antibiotics correlate to the appearance of variant colonies, and which antibiotics 
can eradicate variant colonies. Biofilms are resilient toward chemical and physical challenges due 
to the secretion of extracellular polymeric substance and high cellular density. This makes biofilm 
infections difficult to treat. Some examples of biofilm infections are osteomyelitis and cystic 
fibrosis pneumonia most commonly caused by S. aureus and P. aeruginosa respectively. This 
study uses bioluminescent bacteria, S. aureus SAP231 and P. aeruginosa Xen41 as the test subjects 
for antibiotic efficacy. There are four major components to this study: first, the minimum 
inhibitory concentration of planktonic cells against antibiotics were found. Second, the antibiotic 
delivery mechanism was tested to see if mode of antibiotic delivery has an effect on biofilm 
clearance. Third, antibiotics and combinations of antibiotics are tested against biofilms. Lastly, the 
variant colonies are quantified to see which antibiotics correlate to variant colony formation. The 
results show that biofilm infections are more difficult to treat than planktonic bacteria, and the use 
of multi-combinatory antibiotics are effective at treating biofilm. A combination of antibiotic with 
vancomycin was very effective in reducing biofilm and variant colonies in S. aureus. A 
combination of antibiotic with ciprofloxacin was very effective in reducing biofilm and variant 
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Bacterial biofilms have been correlated with chronic and persistent infections due to the difficulty 
in treating the infection completely with antimicrobial agents.1 Bacterial biofilms form when 
planktonic, free swimming, bacteria attach to a surface and encase themselves in an extracellular 
polymeric substance (EPS).2 The extracellular matrix provides the biofilm with a whole host of 
benefits including resilience towards chemical and physical challenges. Some protective 
mechanisms include poor penetration of antibiotics through the EPS, slow growth of bacteria with 
the efficacy of many antibiotics depending on active growth of bacteria, and the formation of 
persisters, which are a subpopulation of bacteria that are neither able to grow nor die.3 Another 
mechanism is the gaining of antibiotic resistance. Frequent mutations in a high density cell 
population combined with horizontal gene transfer, has led biofilms to contribute to the rise of 
antibiotic resistance.2 All of these tolerant/resistant mechanisms make treating biofilms more 
difficult compared to planktonic infections, where planktonic infections respond well to antibiotic 
treatments.2 Some examples of biofilm related infections include osteomyelitis, cystic fibrosis 
pneumonia, and medical device implant-related infections. Pseudomonas aeruginosa and 
Staphylococcus aureus are some of the most common biofilm forming bacteria that cause 
infection, P. aeruginosa being most common in cystic fibrosis pneumonia and S. aureus being the 
most common in osteomyelitis.1 Combined with the rise of antimicrobial resistances and the 
resilience of biofilms, biofilm-related infections are extremely difficult to treat.  
 
A treatment option for osteomyelitis and other orthopedic related procedures is the use of calcium 
sulfate (CaSO4) beads impregnated with antibiotics.5 These beads are surgically implanted in the 
wound site allowing high localized elution of antibiotics, which is important because biofilms have 
antibiotic tolerant properties.3 The advantage of using these beads is having the capacity to use 
higher concentrations of antibiotics to treat the infection while lowering instances of antibiotic 
induced toxicity because of the localized elution.4 When it comes orthopedics, gentamicin loaded 
bone cement is used during surgeries.17 In an in vitro study testing CaSO4 beads on S. aureus 
biofilms, a gentamicin loaded bead was placed in the center of the biofilm. After 8 days of 
incubation, the use of a gentamicin bead lead to the appearance of variant colonies within the 
biofilm (Figure 1). A similar event was occurring with P. aeruginosa, in which a gentamicin loaded 
beads also led to the appearance of variant colonies after 4 days of incubation (Figure 2). These 
findings were surprising because S. aureus and P. aeruginosa are normally susceptible to 
gentamicin6,7, but over the course of time, variant colonies appeared in what seemed to be a dead 
biofilm. This phenomenon could help explain persistent and chronic infections based on the 
emergence of antibiotic variant colonies within a biofilm.  
 
 
Figure 1: IVIS image shows the effects of a gentamicin CaSO4 bead against S. aureus SAP231 
biofilm. As time progresses, the zone of killing increases. On day 8, variant colonies appeared 
within the zone of killing within the biofilm. Red on the IVIS indicates metabolically active 





Figure 2: IVIS image shows the effect of a gentamicin CaSO4 bead against P. aeruginosa Xen41 
biofilm. As time progresses, the zone of killing increases. On day 4, variant colonies appeared 
within the zone of killing within the biofilm. Red on the IVIS indicates metabolically active 
bacteria while blue indicates less activity. Red dots on the IVIS are identified at variant bacteria. 
 
Variant bacteria, in the context of the colonies seen on the antibiotic loaded plate, is an umbrella 
term that encompasses tolerant, resistant, and other variants of bacteria. Replica plating is a 
technique used to differentiate the variant colonies. In replica plating, the original plate containing 
the colonies is stamped onto a velveteen cloth. Then new agar media containing antibiotic and no 
antibiotic are stamped onto the cloth. This transfers the bacteria from one plate to another keeping 
the same pattern. Variant colonies are classified into 3 categories tolerant, resistant, and viable but 
not culturable (VBNC) (Figure 3). Tolerant being defined as when the bacteria have the ability to 
survive in the presence of antibiotics, but will revert back to being susceptible once re-cultured in 
an antibiotic environment. Resistant is when the bacteria will remain being resistant to an antibiotic 
once removed from and re-cultured onto an antibiotic environment. VBNC colonies appear in the 
initial plate, but are unable to be re-cultured onto new media with and without antibiotics present.  
 
Figure 3: Variant colonies appear on 
IVIS images of Xen41 grown with a 
gentamicin bead. Replica plating was 
done to differentiate the different types 
of variants. The original plate was replica 
plated onto a new plate containing no 
gentamicin and a plate with gentamicin.   
Resistant, tolerant, and VBNC colonies 
can be seen based on the appearance of 
the colony on the original plate compared 
to the replica plates.  
 
 
To investigate the antibiotic variant phenomenon, different antibiotic classes were tested against 
bioluminescent strains of P. aeruginosa and S. aureus, looking for which antibiotics will be most 
effective in treating the biofilm and preventing the appearance of antibiotic variant bacteria. P. 
aeruginosa and S. aureus were chosen not only because they are common bacterial infections, but 
they encompass both gram-positive and gram-negative bacteria. The classification of the bacteria’s 
Gram stain can correlate to which classes of antibiotics the bacteria will be susceptible to. The 
hypothesis here is that other antibiotics can lead to the development of variant colonies and treating 
the biofilm with multidrug combinations will be most effective at eradicating the biofilm and 
reduce variant numbers. The goal of this project is to find which antibiotic(s) will be most effective 
in treating biofilms, which antibiotics correlate to the appearance of variant colonies, and which 




Materials and Methods 
The overview of the experiments can be broken down into 4 parts. First, the minimum inhibitory 
concentration (MIC) was found for each antibiotic against S. aureus and P. aeruginosa to see the 
efficacious dose of the antibiotics, which will be used as a comparison model for planktonic v. 
biofilm bacteria. Second, the antibiotic delivery system is tested to see if the mode of delivery of 
CaSO4 and paper disc will produce significantly different results. Third, single and multidrug 
combinations are tested to see which antibiotic(s) will be most effective in clearing the biofilm. 
Lastly, variant colony formation will be measured to see which antibiotic(s) is most effective in 
clearing or reducing the number of variant colonies.  
 
Materials 1: Bacterial Strains and Imaging  
Pseudomonas aeruginosa Xen41 (Xen41) is a bioluminescent strain of P. aeruginosa derived 
from parental strain PAO1 with an inserted lux operon from Photorhabdus luminescens.8 
Staphylococcus aureus SAP231 (SAP231) is a bioluminescent strain of S. aureus derived from 
USA 300 MRSA with an inserted lux operon from Photorhabdus luminescens.8,11 
In vivo imaging system (IVIS) allows the imaging of bioluminescence. Bacterial metabolic 
activity can be measured with IVIS.   
ImageJ- ImageJ is a program that allows measurements to be made on the IVIS images.14 
 
Materials 2: Antibiotics  
Carbenicillin (Carb) (GoldBio) is a broad-spectrum semisynthetic beta-lactam drug that 
interferes with cell wall synthesis by preventing the cross linking of peptidoglycan.9    
Ciprofloxacin (Cipro) (Sigma-Aldrich) is a broad-spectrum fluoroquinolone that inhibits DNA 
gyrase and topoisomerase IV, which is required for DNA replication. 9   
Colistin Sulfate (Colistin) (GoldBio) is a type of polymyxin that disrupts and change cellular 
membrane permeability due to polycationic properties of colistin being both lipophilic and 
hydrophobic. 9   
Gentamicin Sulfate (G) (GoldBio) is a broad-spectrum aminoglycoside that irreversibly bind to 
30S ribosomal subunit interfering with protein synthesis. 9   
Meropenem (M) (GoldBio) is a broad-spectrum carbapenem that inhibits cell wall synthesis by 
interfering with the cross linking of peptidoglycan. 9   
Rifampicin (R) (GoldBio) is a broad-spectrum semisynthetic antibiotic that inhibits DNA-
dependent RNA polymerase, thus inhibiting RNA synthesis. 9   
Tobramycin Sulfate (T) (GoldBio) is an aminoglycoside that irreversibly binds to the 30S 
ribosomal subunit interfering with protein synthesis. 9   
Vancomycin Hydrochloride (V) (GoldBio) inhibits cell-wall synthesis by preventing N-
acetylmuramic acid and N-acetylglucosamine from binding together by binding to D-Ala-D-Ala 
in the peptidoglycan matrix. 9   
 
Materials 3: Compounding of Antibiotics 
Calcium sulfate beads were made with desired amount of antibiotics with calcium sulfate 
hemihydrate (Sigma-Aldrich) (20g) and distilled water (6mL), casting the paste in 4.2mm bead 
mold and set to dry for 24hrs. The amounts can be scaled depending on how many beads are requir 
Paper discs (6.35mm) (Thermo-Scientific) were made using antibiotic solution. Antibiotic 
solution was made using desired amount of antibiotic with distilled water (1mL). The amount of 




Materials 4: Media and Biofilm Preparation 
Lysogeny broth (LB) and LB agar (LBA) (Fisher Scientific) were used as the nutrient source to 
culture P. aeruginosa. LB was made by suspending LB powder (12.5g) with distilled water 
(500mL) (dH2O) and autoclaving to sterilize the media. LBA was made my suspending LB powder 
(12.5g) with dH2O (500mL) and agar (7.5g). The solution was autoclaved and pipetted (20mL) 
into sterile 100mm*15mm petri dishes (Fisher Scientific). 
Brain Heart Infusion broth (BHI) and BHI agar (BHIA) (Beckton, Dickinson and Company) 
were used as the nutrient source to culture S. aureus. BHI was made by suspending BHI powder 
(18.5g) with distilled water (500mL) (dH2O) and autoclaving. BHIA was made by suspending BHI 
powder (18.5g) with dH2O (500mL) and agar (7.5g) (Fisher Scientific). The solution was 
autoclaved and pipetted (20mL) into sterile 100mm*15mm petri dishes. 
Bacterial biofilms were formed on agar plates. The bacteria were grown in broth culture overnight 
in a shaking incubator at 37°C. The bacterial culture was then diluted to an optical density (OD600) 
of 0.10X (1*106 cells/mL). The diluted culture (100µL) was then spread onto an agar plate using 
a lawn spreader. The agar plate was incubated at 37°C overnight to allow the biofilm to form. 
 
Method 1: Minimum Inhibitory Concentration of Planktonic Bacteria (n=3) 
The minimum inhibitory concentration (MIC) is defined as the lowest concentration of a drug that 
will prevent the visible growth of bacteria.10 This assay was performed to get reference values for 
the efficacy of antibiotics against SAP231 and Xen41 in planktonic form. This data can be used to 
compare planktonic v. biofilm bacteria. The experiment used a 96-well plate with each row 
containing a different antibiotic and each column containing a different concentration. Antibiotic 
solution was diluted down into each well (Table 1) and diluted overnight culture was added, so 
that each well contained a total concentration of 1*106 cells/mL.12 The blanks only contained broth 
and no culture. The 96-well plate was incubated at 37°C for 24hrs. The OD600 was taken via 
microplate reader setting the well with just the broth as a blank. The MIC can be determined based 
on the concentration v. OD600 graph. The values for the MIC were determined based by the bottom 
plateau of the graph, where there were no changed in optical density indicating no growth.  
 
Table 1: MIC 96-Well Plate Set-Up 
Well # 1 2 3 4 5 6 7 8 9 10 11 
Antibiotic 
(µg/mL) 
64 32 16 8 4 2 1 0.5 0.25 0 Blank 
 
Method 2: Antibiotic Elution of CaSO4 and Paper discs (n=3) 
Throughout the course of this study, different modes of antibiotic delivery were used in the 
eradication of biofilm. This experiment was done to account for the similarities and differences 
between the antibiotic delivery materials. Two modes of antibiotic delivery were used, CaSO4 
beads and paper discs. In this experiment, CaSO4 beads and paper discs impregnated with 
gentamicin (1mg) are tested against Xen41. A control group was set up with CaSO4 bead and paper 
disc with no antibiotic added. The antibiotic containing vessels were then placed in the center of 
an agar plate with pre-grown Xen41. Xen41 was incubated for 5 days at 37°C, taking IVIS images 
every 24 hrs. The zones of killing, zones of variance, and zones of biofilm were compared between 
the different treatment materials (Figure 4). An ANOVA test was done to test for significance.13  




Figure 4: In the presence of gentamicin, Xen41 
produced three distinct zones. These zones are 
classified as the zone of killing, where no bacteria 
were able to grow, the zone of variants, where 
variant colonies grew, and the zone of biofilm, 
where the biofilm remained intact. Data for 
experiments 2 and 3 use the radius of the zone to 






Method 3: Efficacy of Single and Combinatory Antibiotic(s) against Biofilm (n=3) 
A preliminary experiment was done to see if the diffusion of the antibiotic is being hindered by 
the agar media. To test this, one antibiotic bead (1mg) was placed onto the center of the agar media. 
BHIA was used with SAP231 and LBA was used with Xen41. The agar media was incubated for 
5 days at 37°C, to let the antibiotic diffuse throughout the plate. Planktonic Xen41 and SAP231 
was spread onto the agar plates and incubated for 24hrs. IVIS images were taken to see if there 
was growth of bacteria on the plate.  
     
This main experiment looked at the efficacy of antibiotics against Xen41 and SAP231 biofilms. 
Xen41 and SAP231 were first tested against carbenicillin (Carb) (1mg), ciprofloxacin (Cipro) 
(1mg), colistin (Colis) (1mg), gentamicin (G) (1mg), meropenem (M) (1mg), rifampicin (R) (1mg 
for Xen41, 2mg for SAP231), tobramycin (T) (1mg), and vancomycin (V) (1mg Xen41, 4mg 
SAP231). Combinatory antibiotics were tested to see if efficacy improves when treating a biofilm. 
Xen41 was tested against T+Carb, T+Colis, T+G, and T+M (1mg of each antibiotic). SAP231 was 
tested against V+G, V+R, V+T, V+R+M, and V+R+T (4mg vancomycin, 1mg gentamicin and 
tobramycin, 2mg meropenem and rifampicin). The amount of antibiotic used were based on 
antibiotic mixing guidelines for CaSO4 beads, if there wasn’t a listed amount for a specific 
antibiotic, 1mg was assigned. The antibiotics were tested against pre-grown biofilm using any of 
the antibiotic delivery methods. The plates were incubated at 37°C taking IVIS images every 
24hrs. Xen41 was incubated for 5 days while SAP231 was incubated for 9 days. The percent 
coverage of the zone of killing, zone of variants, and zone of biofilm was found by using ImageJ 
analysis (Figure 4). The percent zone coverage can be calculated by measuring the area of each 
zones comparing it to the total area of the plate. The zones of killing, zones of variants, and zones 
of biofilm were compared on day 5 for Xen41 and day 9 for SAP231.  
 
𝐴𝑟𝑒𝑎	𝑜𝑓	𝑧𝑜𝑛𝑒 = 𝜋𝑟, 
 
𝐵𝑖𝑜𝑓𝑖𝑙𝑚	𝐸𝑟𝑎𝑑𝑖𝑐𝑎𝑡𝑖𝑜𝑛 = %	𝑍𝑜𝑛𝑒	𝑜𝑓	𝐾𝑖𝑙𝑙𝑖𝑛𝑔 +%	𝑍𝑜𝑛𝑒	𝑜𝑓	𝑉𝑎𝑟𝑖𝑎𝑛𝑡𝑠 
 
To determine the efficacy of the antibiotic and combinations, the zone of killing and zone of 
variants were combined. The zone of variants was included in the data analysis because the 
antibiotic was able to clear the biofilm from this area. Looking at the cellular density of the zone 




complete coverage of bacteria in the zone of biofilm. (To see percent coverage of each zone refer 
to Appendix) A Dunnett test was done to compare the efficacy of other antibiotic against 
gentamicin. A Dunnett test is a statistical comparison of multiple treatment groups against a 
control. Gentamicin is used as the control because it is used as a standard treatment in orthopedics. 
A Turkey test was then used to compare the different antibiotics to each other. A Turkey test is a 
statistical comparison for three or more variables. Similar to the Dunnett test, a Turkey test 
compared the treatment groups to all treatment groups, instead of just one control. From the Turkey 
test the treatment group that performed the best in eradicating the biofilm can be determined. 
 
Method 4: Quantifying Variant Colonies via Colony Density (n=3) 
The variant colonies were quantified to see if certain classes of antibiotics had favorable conditions 
for variant bacteria appearance and which antibiotic had the fewer variant colonies. The antibiotics 
and combinations of antibiotics used is listed in Experiment 3. To quantify the number of variant 
colonies, IVIS images was used. The color scale of the IVIS image indicates metabolic activity 
with the color red indicating high activity and blue indicating low activity. A red dot on the IVIS 
image indicates a metabolically active variant colony. The variant colonies accounted for are 
tolerant, resistant, and VBNC phenotype. The total number of variant colonies were found by 
dividing the zone of variants on the IVIS image into 4 quadrants (Figure 5). The number of colonies 
were counted in one quadrant and multiplied by 4 to get the total number. The area within the zone 
of variants was also found by multiplying the percentage of the area in the IVIS image by the total 
area of the actual plate. The number of variant colonies per area was compared between each 
susceptible antibiotics and combinations. 
 
#	𝑜𝑓	𝑣𝑎𝑟𝑖𝑎𝑛𝑡	𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 = #	𝑜𝑓	𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠	𝑖𝑛	𝑎	𝑞𝑢𝑎𝑑𝑟𝑎𝑛𝑡 ∗ 4 
 






Figure 5: To quantify the variant colonies within the zone 
of variants the zone is divided into 4 sections. The number 
of colonies were counted and multiplied by 4 for the total 
count. The area of the zone was found in respect to the 








A Dunnett test was done to compare the colony density of the different treatment groups. 
Gentamicin was used as the control group. A Turkey test was then used to compare all the 
treatment group to each other. From the Turkey test, the best treatment option that lead to the 




Results and Analysis 
Results 1: MIC for Planktonic SAP231 and Xen41 
 
Graph 1: The concentrations of antibiotic that inhibits the growth of SAP231. SAP231 showed 
resistance towards carbenicillin and colistin while being susceptible to ciprofloxacin, gentamicin, 
meropenem, rifampicin, tobramycin, and vancomycin. 
 
 
Graph 2: The concentrations of antibiotic that inhibits the growth of Xen41. Xen41 showed 
resistance towards carbenicillin and vancomycin, while being susceptible towards ciprofloxacin, 
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Concentration of Antibiotic (ug/mL)
Minimum Inhibitroy Concentration of Planktonic Xen41
Carbenicillin Ciprofloxacin Colistin Gentamicin




Table 2: MIC of Planktonic Bacteria 
Antibiotics SAP231 Xen41 
Carbenicillin Resistant Resistant 
Ciprofloxacin 8µg/mL 0.5µg/mL 
Colistin Resistant 16µg/mL 
Gentamicin 32µg/mL 8µg/mL 
Meropenem 8µg/mL 4µg/mL 
Rifampicin 0.25µg/mL 16µg/mL 
Tobramycin 32µg/mL 4µg/mL 
Vancomycin 4µg/mL Resistant 
 
The MIC of each antibiotic was found for Xen41 and SAP231. The MICs were measure by looking 
at the Concentration of Antibiotic vs OD600 graphs. The values were determined by the bottom 
plateau of the graph where the OD remained stagnant, which indicates no growth. Planktonic 
SAP231 and Xen41 were both susceptible to six of the eight antibiotics (Table 1). Rifampicin is 
most potent towards SAP231, while ciprofloxacin was most potent towards Xen41. Potency is 
determined by the amount of drug required to produce an effect.    
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Graph 3: The elution of gentamicin on Xen41 biofilm can be seen over the course of 5 days. The 
zone of killing gradually increase with the appearance of a variant zone on day 4. These graphs 
show the elution kinetics between two different antibiotics containing vessels CaSO4 beads and 
paper discs. (As a control, the biofilm remained intact 100% all 5 days with just CaSO4 bead and 
paper disc with no antibiotics. (Percentages based on a 78.53cm2 biofilm.) 
 
The elution of gentamicin can be seen on Xen41 over the course of time and with the different 
materials (Figure 2, Graph 3). Day 0 indicates the state of the biofilm when the antibiotic is first 
placed. The biofilm is completely intact on Day 0. As the antibiotic elutes outwards the zone of 
killing is increased. Day 4 is when variant colonies appear which is indicated by the zone of 
variants. It is worth noting that the zone of variants shows up within the zone of killing thus 
decreasing the zone of killing.  
 
Graph 4: The box and whisker plots graphed the means 
of the biofilm eradication of two different antibiotic 
materials, CaSO4 beads and paper discs. Biofilm 
eradication takes into account the combined areas of the 
zone of killing and the zone of variants. The y-axis 
shows the biofilm eradication while the x-axis shows 
the different materials. It is concluded that there is no 
statistical difference between the two materials with a 






To test the significance of the data between the two materials, an ANOVA test was done. This test 
can show that the treatment groups performed similarly or can yield statistically different results. 
The null hypothesis is that there is no difference between the two treatment groups. The alternative 
hypothesis is that there is a difference between the two treatment groups. The ANOVA test showed 
that the data yielded a p-value of 0.533. Using a confidence level of 0.05 with the p-value being 
greater than 0.05 (0.533>0.05), we fail to reject the null hypothesis concluding that there is no 
difference between the treatment groups. 
 
Results 3: Single and Combinatory Antibiotic(s) against Biofilm 
Table 3: Preliminary Experiment: Antibiotic Elution on Agar Plate after 5 Days 
Antibiotics SAP231 Xen41 
Carbenicillin Complete Growth Few Colonies  
Ciprofloxacin Few Colonies  No Growth 
Colistin Complete Growth No Growth 
Gentamicin No Growth No Growth 
Meropenem No Growth No Growth 
Rifampicin No Growth Few Colonies 
Tobramycin No Growth No Growth 




The preliminary experiment shows that the antibiotic is not hindered by the agar. The results show 
that the antibiotic was able to diffuse completely throughout the agar plate reaching MIC high 
enough to prevent the growth of bacteria. The actual concentration of antibiotic in the agar is 
unknown because it is unknown if the antibiotic in the bead completely diffused out into the media. 
Assuming if all the antibiotic did diffuse out the maximum concentration of antibiotic on the plate 
is 50µg/mL. The concentration of antibiotic on the plate is somewhere between 50µg/mL and the 





20𝑚𝐿 = 50µ𝑔/𝑚𝐿 
 
Comparing these results to planktonic susceptibility, it is worth noting that carbenicillin is shown 
as resistant according to the OD growth curve. On the agar plate it appears that Xen41 is 
susceptible to carbenicillin. Overall, after 5 days of incubation the concentration of antibiotic on 
the plate should be enough to inhibit the growth of bacteria. 
 
 
Graph 5: Biofilm eradication is measured by combining the zone of killing and the zone of 
variants. Biofilm eradication was compared to gentamicin.  An asterisk (*) marks significance. An 
asterisk below the average of gentamicin, set by the blue line, indicates significantly less, while an 
asterisk above the line indicates significantly more. (Percentages based on 78.53cm2 biofilm.) 
 
Out of the single antibiotics, carbenicillin, colistin, and meropenem were not able to eradicate the 
biofilm. Comparing this to the results of planktonic eradication, meropenem was effective against 
planktonic bacteria, but not towards a biofilm. Carbenicillin and colistin did not have an effect on 
planktonic and biofilm bacteria, thus concluding that SAP231 is resistant towards these two 


















































Table 4: Dunnett Test- Biofilm Eradication of SAP231 
Comparison Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted P Value 
G vs. Carb -0.6203 -0.7573 to -0.4833 Yes **** <0.0001 
G vs. Cipro 0.03771 -0.09927 to 0.1747 No ns 0.9978 
G vs. Colistin  -0.6203 -0.7573 to -0.4833 Yes **** <0.0001 
G vs. M 0.6203 0.4833 to 0.7573 Yes **** <0.0001 
G vs. R 0.0982 -0.03878 to 0.2352 No ns 0.3552 
G vs. T -0.04665 -0.1836 to 0.09034 No ns 0.9862 
G vs. V 0.03515 -0.1018 to 0.1721 No ns 0.9988 
G vs. V+G -0.1679 -0.3048 to -0.03088 Yes ** 0.0073 
G vs. V+R -0.07659 -0.2136 to 0.06039 No ns 0.7048 
G vs. V+T -0.1601 -0.2971 to -0.02313 Yes * 0.0121 
G vs. VRT -0.3797 -0.5167 to -0.2427 Yes **** <0.0001 
G vs. VRM -0.3797 -0.5167 to -0.2427 Yes **** <0.0001 
Table 4: A Dunnett test was done to compare the treatment groups towards the control, 
gentamicin. Alpha level was set at 0.05. Gray highlighted box indicates no significance, red 
highlight box indicates significantly less, and a green highlighted box indicates significantly more. 
 
A Dunnett test was done to compare the other treatment groups towards the control, gentamicin. 
The treatment using ciprofloxacin, rifampicin, tobramycin, vancomycin, and V+R did not produce 
any significant results than gentamicin. Treatment using carbenicillin, colistin, and meropenem 
eradicated the biofilm significantly.  Looking at the combinatory antibiotic, V+G, V+T, VRT, and 
VRM performed significantly better than gentamicin (Table 4).  
 
Table 5: Turkey Test- Biofilm Eradication of SAP231 
Comparison Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted P Value 
VRM vs. VRT 0 -0.137 to 0.137 No ns >0.9999 
VRM vs. V+T -0.2196 -0.3566 to -0.08258 Yes *** 0.0002 
VRM vs. V+G  -0.2118 -0.3488 to -0.07483 Yes *** 0.0004 
VRT vs. V+T  -0.2196 -0.3566 to -0.08258 Yes *** 0.0002 
VRT vs. V+G -0.2118 -0.3488 to -0.07483 Yes *** 0.0004 
V+G vs. V+T 0.007748 -0.1292 to 0.1447 No ns >0.9999 
Table 5: A Turkey test compared antibiotic treatment group to all other treatment group. Alpha 
level was set at 0.05. These values show only the comparisons that performed significantly better 
than gentamicin. Gray highlighted box indicates no significance and a green box indicates 
significantly more.  
 
A Turkey test was done to find out which treatment group eradicated the biofilm the best. Out of 
the 78 comparisons, the treatment groups that performed the better than gentamicin are listed 
(Table 5). Overall the triple combination of VRT and VRM performed significantly better than the 
double combination of V+G and V+T. There is no significance between VRT and VRM. Thus, 
this concludes that combinatory antibiotics were most effective with VRT and VRM being the best 





Graph 6: Biofilm eradication is measured by combining the zone of killing and the zone of 
variants. Biofilm eradication was compared to gentamicin.  An asterisk (*) marks significance. An 
asterisk below the average of gentamicin, set by the blue line, indicates significantly less, while an 
asterisk above the line indicates significantly more. (Percentages based on 78.53cm2 biofilm.) 
 
Table 6: Dunnett Test- Biofilm Eradication of Xen41 
Dunnentt Test Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted P Value 
G vs. Carb -0.5861 -0.6308 to -0.5414 Yes **** <0.0001 
G vs. Cipro -0.3963 -0.441 to -0.3515 Yes **** <0.0001 
G vs. Colistin  -0.5179 -0.5626 to -0.4732 Yes **** <0.0001 
G vs. M 0.5861 0.5414 to 0.6308 Yes **** <0.0001 
G vs. R 0.5861 0.5414 to 0.6308 Yes **** <0.0001 
G vs. T -0.07004 -0.1148 to -0.02532 Yes *** 0.0003 
G vs. V 0.5861 0.5414 to 0.6308 Yes **** <0.0001 
G vs. T+Carb -0.2914 -0.3361 to -0.2467 Yes **** <0.0001 
G vs. T+Cipro -0.04701 -0.0917 to -0.002298 Yes * 0.0329 
G vs. T+Colistin -0.1535 -0.1983 to -0.1088 Yes **** <0.0001 
G vs. T+G -0.3144 -0.3592 to -0.2697 Yes **** <0.0001 
G vs. T+M -0.1029 -0.1476 to -0.05815 Yes **** <0.0001 
Table 6: A Dunnett test was done to compare the treatment groups towards the control, 
gentamicin. Alpha level was set at 0.05. Red highlight box indicates significantly less, and a green 


























































Out of the single antibiotics, carbenicillin, meropenem, rifampicin, and vancomycin were not able 
to eradicate the biofilm. Comparing this to the results of planktonic eradication, meropenem and 
rifampicin are effective against planktonic bacteria, but not towards a biofilm. Carbenicillin and 
vancomycin did not have an effect on planktonic and biofilm bacteria, thus concluding that Xen41 
is resistant towards these two antibiotics. All of the double combination and tobramycin have high 
clearance of biofilm. 
 
A Dunnett test was done to compare the other treatment groups towards the control, gentamicin. 
All of the treatment group produced significant results. Out of the single antibiotics, tobramycin 
performed significantly better than gentamicin with all other single antibiotics, ciprofloxacin, 
colistin, carbenicillin, meropenem, rifampicin, and vancomycin, performed significantly worse. 
All of the combinatory antibiotics, T-Carb, T-Cipro, T-Colistin, T+G, and T+M performed 
significantly better than gentamicin.  
 
Table 7: Turkey Test- Biofilm Eradication of SAP231 
Dunnentt Test Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted P Value 
T+Carb vs. T -0.2214 -0.2661 to -0.1766 Yes **** <0.0001 
T+Cipro vs. T 0.02303 -0.02169 to 0.06774 No ns 0.7966 
T+Colistin vs. T -0.0835 -0.1282 to -0.03879 Yes **** <0.0001 
T+G vs. T -0.2444 -0.2891 to -0.1997 Yes **** <0.0001 
T+M vs. T -0.03282 -0.07754 to 0.01189 No ns 0.3227 
T+Carb vs. T+Colisin 0.1379 0.09314 to 0.1826 Yes **** <0.0001 
T+Carb vs. T+G -0.02306 -0.06777 to 0.02166 No ns 0.7953 
T+G vs. T+Colistin -0.1609 -0.2056 to -0.1162 Yes **** <0.0001 
Table 5: A Turkey test compared antibiotic treatment group to all other treatment group. Alpha 
level was set at 0.05. These values show only the comparisons that performed significantly better 
than gentamicin. Gray highlighted box indicates no significance and a green box indicates 
significantly more.  
 
A Turkey test was done to find out which treatment group eradicated the biofilm the best. Out of 
the 78 comparisons, the treatment groups that performed the better than gentamicin are listed 
(Table 7). First, the comparison of the other antibiotics was done against tobramycin, since 
tobramycin was the only single antibiotic that performed better than gentamicin. It is concluded 
that the double combination, T+Carb, T+Colistin, and T+G performed better than tobramycin 
alone, while T+Cipro and T+M were not significantly different. Out of T+Carb, T+G, and 
T+Colistin, T+Carb and T+G performed better than T+Colistin and were not significantly different 












Result 4: Colony Density of Variant Colonies  
 
Graph 7: Variant colony density was found by quantifying the number of variant colonies in the 
zone of variants dividing the total area of the zone. Variant colony density was compared against 
gentamicin. An asterisk (*) marks significance. An asterisk below the average of gentamicin, set 
by the blue line, indicates significantly fewer colonies. 
 
Out of the single antibiotics, gentamicin and tobramycin are correlated with the highest number of 
variant colonies. Gentamicin and tobramycin are both aminoglycoside, which means there might 
be a correlation between variant colony appearance and aminoglycosides. Vancomycin was the 
only treatment option that had zero variant colonies.  
 
Table 8: Dunnett Test- Variant Colony Density of SAP231 
Comparison Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted P Value 
G vs Cipro -5.143 -7.872 to -2.415 Yes **** <0.0001 
G vs. R 3.703 0.9739 to 6.431 Yes ** 0.0022 
G vs. T 2.257 -0.4716 to 4.986 No ns 0.1807 
G vs. V 7.378 4.649 to 10.11 Yes **** <0.0001 
G vs. V+G 1.029 -1.7 to 3.757 No ns 0.9699 
G vs. V+R 1.032 -1.696 to 3.761 No ns 0.9692 
G vs. V+T 2.663 -0.06613 to 5.391 No ns 0.0606 
G vs. VRT 6.691 3.963 to 9.42 Yes **** <0.0001 







































Table 8: A Dunnett test was done to compare the treatment groups towards the control, 
gentamicin. Alpha level was set at 0.05. Gray highlighted box indicates no significance, red 
highlight box indicates significantly less variant colony density. 
 
Using a Dunnett test comparing treatment groups to gentamicin (Table 8), only ciprofloxacin, 
rifampicin, and vancomycin had significantly fewer colonies. Fewer colonies would indicate a 
better treatment option. Compared to the combinatory antibiotics, it is surprising to see that the 
treatment with V+R, V+T, and V+G are not significantly different from gentamicin. However, the 
triple combination of VRT and VRM did have significantly fewer variants. 
 
Table 9: Turkey Test- Variant Colony Density of SAP231 
Comparison Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted P Value 
V vs. Cipro 2.235 -0.4942 to 4.963 No ns 0.191 
V vs. R 3.675 0.9467 to 6.404 Yes ** 0.0025 
V vs. VRT -0.6867 -3.415 to 2.042 No ns 0.999 
V vs. VRM -3.811 -6.54 to -1.083 Yes ** 0.0016 
VRT vs. Cipro 1.548 -1.181 to 4.276 No ns 0.6868 
VRT vs. VRM -3.125 -5.853 to -0.3959 Yes * 0.0148 
VRT vs. R 2.989 0.26 to 5.717 Yes * 0.0227 
Cipro vs. R -1.441 -4.17 to 1.288 No ns 0.7708 
Cipro vs. VRM -1.577 -4.305 to 1.152 No ns 0.6629 
Rifampicin vs. VRM -0.1358 -2.865 to 2.593 No ns >0.9999 
Table 9: A Turkey test compared antibiotic treatment group to all other treatment group. Alpha 
level was set at 0.05. These values show only the comparisons that performed significantly better 
than gentamicin. In this case, having fewer colonies means it is a better treatment. Gray highlighted 
box indicates no significance and a red box indicates significantly less.  
 
The Turkey test compared each treatment group to each other (Table 9). The values selected for 
the table were the treatment groups that performed better than gentamicin. Since vancomycin had 
the least average of variant colonies, it was compared against all other treatment groups. The 
results show that ciprofloxacin and the combination VRT were not significantly different from 
vancomycin. This concludes that vancomycin, ciprofloxacin, and VRT were the best treatment 






Graph 8: Variant colony density was found by quantifying the number of variant colonies in the 
zone of variants dividing the total area of the zone. Variant colony density was compared against 
gentamicin. An asterisk (*) marks significance. An asterisk below the average of gentamicin, set 
by the blue line, indicates significantly fewer colonies. 
 
Out of the single antibiotics, gentamicin and tobramycin are correlated with the highest number of 
variant colonies similarly to SAP231. Aminoglycosides had the highest variant colony appearance. 
Only three of the treatment groups, ciprofloxacin, colistin and T+Cipro, had zero variant colonies.  
 
Table 10: Dunnett Test- Variant Colony Density of Xen41 
Comparison Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted P Value 
G vs Cipro -6.449 -7.187 to -5.711 Yes **** <0.0001 
G vs. Colistin -6.449 -7.187 to -5.711 Yes **** <0.0001 
G vs. T 1.027 0.2886 to 1.765 Yes ** 0.0016 
G vs. T+Carb 5.506 4.768 to 6.244 Yes **** <0.0001 
G vs. T+Cipro 6.449 5.711 to 7.187 Yes **** <0.0001 
G vs. T+Colistin 3.566 2.828 to 4.304 Yes **** <0.0001 
G vs. T+G 2.84 2.102 to 3.578 Yes **** <0.0001 
G vs. T+M 5.248 4.51 to 5.986 Yes **** <0.0001 
Table 10: A Dunnett test was done to compare the treatment groups towards the control, 
gentamicin. Alpha level was set at 0.05. Gray highlighted box indicates no significance, red 







































Using a Dunnett test comparing treatment groups to gentamicin (Table 10), all of the single 
antibiotics, ciprofloxacin, colistin, and tobramycin had significantly fewer colonies than 
gentamicin. Fewer colonies would indicate a better treatment option. All of the combinatory 
antibiotics, T+Carb, T+Cipro, T+Colistin, T+G, and T+M had significantly fewer variants than 
gentamicin.  
 
Table 11: Turkey Test- Variant Colony Density of Xen41 
Comparison Mean Diff. 95.00% CI of diff. Significant? Summary Adjusted P Value 
Cipro vs. Colistin 0 -0.738 to 0.738 No ns >0.9999 
Cipro vs. T -5.422 -6.16 to -4.684 Yes **** <0.0001 
Cipro vs. T+Carb -0.9423 -1.68 to -0.2043 Yes ** 0.0046 
Cipro vs. T+Cipro 0 -0.738 to 0.738 No ns >0.9999 
Cipro vs. T+Colistin -2.882 -3.62 to -2.144 Yes **** <0.0001 
Cipro vs. T+G -3.609 -4.347 to -2.871 Yes **** <0.0001 
Cipro vs. T+M -1.2 -1.938 to -0.4624 Yes *** 0.0002 
Colistin vs. T+Cipro 0 -0.738 to 0.738 No ns >0.9999 
Table 11: A Turkey test compared antibiotic treatment group to all other treatment group. Alpha 
level was set at 0.05. These values show only the comparisons that performed significantly better 
than gentamicin. In this case, having fewer colonies means it is a better treatment. Gray highlighted 
box indicates no significance and a red box indicates significantly less.  
 
The Turkey test compared each treatment group to each other (Table 11). Not all of the values are 
listed above. Since ciprofloxacin, colistin, and T+Cipro, had the same mean of 0, the mean 
difference and adjusted p-value are the same as the comparison of ciprofloxacin vs. all other drugs. 
The results show that ciprofloxacin, colistin, and T+Cipro had the fewest variant colonies and that 
they themselves are not significantly better to each other. This means that ciprofloxacin, colistin, 
and T+Cipro are the best treatment options for variant colony reduction in Xen41. 
 
Discussion 
From the data shown, biofilms are more resilient towards antibiotic treatment. Comparing the MIC 
values of planktonic bacteria and the susceptibility of biofilms, SAP231 and Xen41 are more 
susceptible when planktonic. SAP231 was susceptible towards ciprofloxacin, meropenem, 
gentamicin, rifampicin, tobramycin, and vancomycin when planktonic (Table 2), but when it is in 
a biofilm, SAP231 was not susceptible towards meropenem (Graph 5). Xen41 was susceptible 
towards carbenicillin (Table 3), ciprofloxacin, colistin, meropenem, gentamicin, rifampicin, and 
tobramycin when planktonic (Table 2), but when it is in a biofilm, Xen41 was not susceptible 
towards meropenem and rifampicin (Graph 7). From the results, when Xen41 was in a biofilm 
beta-lactam drugs like meropenem and carbenicillin were not susceptible at clearing the biofilm 
compared to the preliminary susceptibility test (Table 3). A similar event happened with SAP231, 
where meropenem was not able to kill the biofilm, while carbenicillin was resistant. Based on these 
observations, there might be some mechanisms of the biofilm that is inhibiting the efficacy of beta-





Although bacterial biofilms are susceptible towards some of the antibiotics, large portions of the 
biofilm remained intact after incubation with antibiotics. None of the single combination 
antibiotics were able to completely eradicate the zone of biofilm of SAP231 or Xen41. It is found 
that the concentration of antibiotic can diffuse well above the MIC (Table 3). This could mean the 
biofilm is preventing the penetration and diffusion of antibiotic or the biofilm itself is becoming 
tolerant towards the antibiotics. It is hypothesized that the antibiotics that did not lead to variant 
colonies, like colistin and ciprofloxacin for Xen41 (Graph 6) and vancomycin for SAP231 (Graph 
5), the antibiotic was not able to diffuse thoroughly throughout the plate because no variant 
colonies formed, and the biofilm was not completely eradicated. The antibiotics that lead to the 
appearance of variant colonies might be gaining tolerance and resistances towards the antibiotic 
because the variant colonies expressed those phenotypes when re-plated onto fresh agar.  
 
Variant colonies encompass many phenotypes from tolerant to resistant. It appears that there is 
some relationship between aminoglycosides, like tobramycin and gentamicin, and the appearance 
of variant colonies. Both antibiotics had the highest variant cell density of any of antibiotic in 
SAP231 and Xen41 (Graph 7 and 9). Looking at SAP231, the variants of rifampicin and 
ciprofloxacin are probably an induced genetic mutation that allows the bacteria to gain resistance 
since the colony density was much lower than the aminoglycosides like gentamicin and 
tobramycin. It is found that a single base pair change in the b sub-unit of RNA polymerase confers 
with high levels of rifampicin resistance.15 Similarly with ciprofloxacin resistance, an amino acid 
substitution can decrease the binding affinity of ciprofloxacin to DNA gyrase or topoisomerase 
IV.16 Ciprofloxacin and rifampicin have the highest area of killing (Graph 5) with the lowest 
variant colony density (Graph 9). This would also explain why the MIC elevated to resistant after 
5 days of incubation (Table 2).  
 







































































The summary table highlights the important findings in this study. Antibiotic treatment options are 
ranked according to their efficacy. For planktonic bacteria, the rankings were done according to 




antibiotics are effective in treating planktonic bacteria. When it comes to biofilms, antibiotic 
efficacy was ranked according to biofilm clearance. Over all combinatory antibiotics worked best 
with triple combination of VRT and VRM being effective in treating SAP231 and double 
combination of T+G and T+Carb being effective in treating Xen41. Variant colonies were ranked 
according to which antibiotic had the fewest colonies with vancomycin working best towards 
SAP231 with zero colony appearance. T+Cipro, ciprofloxacin, and colistin worked best with zero 
variant colony appearance. It is important to note there was not a single combination that worked 
best at clearing the biofilm and had the fewest variant colonies. It is important to weigh the risk 
and benefits of the different treatment options. Some instances using the combination of antibiotic 
that is able to clear the biofilm is better because it does reduce the number of bacteria in the host 
and in this case the host immune system can fight against the variant bacteria. Another instance if 
the host immune system is compromised choosing a combination that had the fewest variant 
colonies may be better because the host immune system may not be strong enough to fight variants. 
Looking at the summary table based on the number of times a certain antibiotic appeared, 




Differentiating if an infection is a biofilm is important because it does significantly change how 
physicians should approach the infection. Treating biofilms are more difficult than treating 
planktonic infections, as seen in this in vitro study. None of the antibiotics were able to completely 
eradicate the biofilm, but were effective at killing or preventing growth in planktonic cultures. 
When compared to antibiotic susceptibility of planktonic vs biofilm, some antibiotics may not be 
effective at treating biofilms although they are effective when planktonic. The appearance of 
variant colonies with the use of antibiotics is concerning because it shows that antibiotic treatment 
is not as effective at killing the pathogen as thought. The antibiotics may look like it is susceptible 
and effective for the first couple days, but as time progresses, it can give rise to these variant 
bacteria. Treating variant bacteria may be more difficult than treating the original pathogen as 
these variants are able to survive the effects of the antibiotic. It is unsure if these variant colonies 
have an impact in vivo, but looking at the in vitro study, variants are able to survive high 
concentration of antibiotic well above the MIC compared to planktonic bacteria. Accounting for 
variants, it is important to use the most effective antibiotic treatment that has the greatest efficacy 
towards the pathogen without inducing the growth of variants. Using a combination of antibiotics 
with multiple different mechanism of action can best clear a biofilm.  It is also important to have 
many effective combinations of antibiotics to slow the development of antibiotic resistance.  
 
Future Work 
The future of this project is to investigate if the variant phenomenon occurs in vivo, using a wax 
worm model (Project led by Devin Sindeldecker). Currently, P. aeruginosa mutants are being 
screened to look to see if there is a transcriptional change that is related to the appearance of variant 
colonies. The idea is to translate the findings of antibiotics combinations to these mutants to see if 
the results and findings are similar. In vitro tests on clinical isolates have shown that this variant 
phenomenon is occurring. Some clinical isolates that have been tested do not show the same 
susceptibility pattern as Xen41. Further antibiotic combination testing will be looked at, 






Different Zones Encompassment on SAP231 Biofilm Day 9 
Rank Antibiotics Zone of Killing Zone of Variants Zone of Biofilm 
1 VRM 58.5% 41.4% 0% 
1 V 58.5% 0% 41.4% 
2 VRT 57.6% 42.3% 0% 
3 V+T 52.3% 25.7% 21.9% 
4 V+G 52.1% 26.6% 21.8% 
5 T 44.4% 22.2% 33.3% 
6 V+R 40.1% 29.5% 30.3% 
7 G 37.5% 26.2% 37.9% 
8 Cipro 2.15% 63.6% 34.1% 
9 R 2.08% 50.1% 47.7% 
10 Carb Not Susceptible 100% Biofilm 
10 Colistin Not Susceptible 100% Biofilm 
10 M Not Susceptible 100% Biofilm 
This tables shows the zone percent encompassment of each zone in SAP231 biofilm. Biofilm 
eradication included both the zone of killing and the zone of variants. (Percentages based on 
78.53cm2 biofilm.) 
 
Different Zones Encompassment on Xen41 Biofilm Day 5 
Rank Antibiotics Zone of Killing Zone of Variants Zone of Biofilm 
1 T+Cipro 58.5% 0% 36.6% 
2 T+M 42.1% 26.7% 31.1% 
3 T+G 34.5% 55.4% 9.94% 
4 T 28.0% 37.5% 34.3% 
5 T+Colistin 25.4% 48.4% 48.4% 
6 T+Carb 20.8% 66.8% 66.8% 
7 Cipro 18.9% 0% 81.0% 
8 G 12.5% 46% 43.1% 
9 Colistin 6.8% 0% 93.1% 
10 Carb Not Susceptible 100% Biofilm 
10 M Not Susceptible 100% Biofilm 
10 R Not Susceptible 100% Biofilm 
10 V Not Susceptible 100% Biofilm 
This tables shows the zone percent encompassment of each zone in Xen41 biofilm. Biofilm 
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